Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Solid Tumors × Folfox protocol × Clear all

Sponsor

Conditions

Colorectal Neoplasms 18 Rectal Neoplasms 10 Colonic Neoplasms 6 Pancreatic Neoplasms 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Adenocarcinoma Of Esophagus 3 Neoplasms 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Neuropathy, Painful 1 Neuralgia 1 Neoplasm Recurrence, Local 1 Malignant Solid Tumour 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Esophageal Squamous Cell Carcinoma 1 Cold Hypersensitivity 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Advanced Rectal Cancer 1 Adenocarcinoma of the Lower Rectum 1

Interventions

tislelizumab 4 Docetaxel 4 talazoparib 3 PM 01183 2 Nivolumab 2 MLN 8237 2 Itraconazole 2 Cisplatin 2 Carboplatin 2 zimberelimab 1 sitravatinib 1 sapanisertib 1 pexidartinib 1 pevonedistat 1 peposertib 1 pembrolizumab 1 niraparib 1 mogamulizumab 1 lenvatinib 1 ixabepilone 1 eribulin 1 dalotuzumab 1 avelumab 1 ascrinvacumab 1 TLC 388 1 Rifampin 1 Paclitaxel 1 N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide 1 N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1 Maximum Tolerated Dose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡